Dermapharm Holding Pink Sheet Forward View - Simple Moving Average
| DMPHF Stock | 39.56 0.00 0.00% |
Dermapharm Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Dermapharm Holding's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 30th of January 2026 the relative strength index (rsi) of Dermapharm Holding's share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Dermapharm Holding hype-based prediction, you can estimate the value of Dermapharm Holding SE from the perspective of Dermapharm Holding response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Dermapharm Holding SE on the next trading day is expected to be 39.56 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Dermapharm Holding after-hype prediction price | USD 39.56 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Dermapharm |
Dermapharm Holding Additional Predictive Modules
Most predictive techniques to examine Dermapharm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dermapharm using various technical indicators. When you analyze Dermapharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Dermapharm Holding Simple Moving Average Price Forecast For the 31st of January
Given 90 days horizon, the Simple Moving Average forecasted value of Dermapharm Holding SE on the next trading day is expected to be 39.56 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.Please note that although there have been many attempts to predict Dermapharm Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Dermapharm Holding's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Dermapharm Holding Pink Sheet Forecast Pattern
| Backtest Dermapharm Holding | Dermapharm Holding Price Prediction | Buy or Sell Advice |
Dermapharm Holding Forecasted Value
In the context of forecasting Dermapharm Holding's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Dermapharm Holding's downside and upside margins for the forecasting period are 39.56 and 39.56, respectively. We have considered Dermapharm Holding's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Dermapharm Holding pink sheet data series using in forecasting. Note that when a statistical model is used to represent Dermapharm Holding pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | -9.223372036854776E14 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Dermapharm Holding
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Dermapharm Holding. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Dermapharm Holding After-Hype Price Density Analysis
As far as predicting the price of Dermapharm Holding at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Dermapharm Holding or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Dermapharm Holding, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Dermapharm Holding Estimiated After-Hype Price Volatility
In the context of predicting Dermapharm Holding's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Dermapharm Holding's historical news coverage. Dermapharm Holding's after-hype downside and upside margins for the prediction period are 39.56 and 39.56, respectively. We have considered Dermapharm Holding's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Dermapharm Holding is very steady at this time. Analysis and calculation of next after-hype price of Dermapharm Holding is based on 3 months time horizon.
Dermapharm Holding Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Dermapharm Holding is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dermapharm Holding backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dermapharm Holding, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
39.56 | 39.56 | 0.00 |
|
Dermapharm Holding Hype Timeline
Dermapharm Holding is currently traded for 39.56. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Dermapharm is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Dermapharm Holding is about 0.0%, with the expected price after the next announcement by competition of 39.56. About 65.0% of the company shares are held by company insiders. The book value of Dermapharm Holding was currently reported as 9.36. The company last dividend was issued on the 18th of June 2020. Assuming the 90 days horizon the next forecasted press release will be in a few days. Check out Historical Fundamental Analysis of Dermapharm Holding to cross-verify your projections.Dermapharm Holding Related Hype Analysis
Having access to credible news sources related to Dermapharm Holding's direct competition is more important than ever and may enhance your ability to predict Dermapharm Holding's future price movements. Getting to know how Dermapharm Holding's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Dermapharm Holding may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HTSUF | Hisamitsu Pharmaceutical Co | 0.00 | 0 per month | 0.00 | 0.23 | 17.37 | (10.40) | 2.63 | |
| TSMRF | Tsumura Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CHSYF | China Medical System | 0.00 | 0 per month | 0.00 | 0.06 | 0.00 | 0.00 | 89.50 | |
| SHPHF | Sihuan Pharmaceutical Holdings | 0.00 | 0 per month | 0.00 | 0.1 | 0.00 | 0.00 | 133.81 | |
| CURLF | Curaleaf Holdings | 0.00 | 0 per month | 0.00 | (0.01) | 9.88 | (10.45) | 69.91 | |
| ARSUF | Fagron NV | 0.00 | 0 per month | 0.00 | 0.09 | 0.00 | 0.00 | 14.09 | |
| LBTSF | Almirall SA | 0.00 | 0 per month | 0.00 | 0.09 | 0.00 | 0.00 | 15.79 | |
| CASBF | CanSino Biologics | 0.00 | 0 per month | 0.00 | (0.11) | 0.00 | (3.60) | 18.06 | |
| HMDCF | HUTCHMED Limited | 0.00 | 0 per month | 0.00 | (0.20) | 0.00 | 0.00 | 12.84 | |
| BRCTF | BioArctic AB | 0.00 | 0 per month | 0.00 | 0.05 | 2.65 | 0.00 | 13.50 |
Other Forecasting Options for Dermapharm Holding
For every potential investor in Dermapharm, whether a beginner or expert, Dermapharm Holding's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dermapharm Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dermapharm. Basic forecasting techniques help filter out the noise by identifying Dermapharm Holding's price trends.Dermapharm Holding Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dermapharm Holding pink sheet to make a market-neutral strategy. Peer analysis of Dermapharm Holding could also be used in its relative valuation, which is a method of valuing Dermapharm Holding by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Dermapharm Holding Market Strength Events
Market strength indicators help investors to evaluate how Dermapharm Holding pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dermapharm Holding shares will generate the highest return on investment. By undertsting and applying Dermapharm Holding pink sheet market strength indicators, traders can identify Dermapharm Holding SE entry and exit signals to maximize returns.
Story Coverage note for Dermapharm Holding
The number of cover stories for Dermapharm Holding depends on current market conditions and Dermapharm Holding's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dermapharm Holding is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dermapharm Holding's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Dermapharm Pink Sheet
Dermapharm Holding financial ratios help investors to determine whether Dermapharm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dermapharm with respect to the benefits of owning Dermapharm Holding security.